Tag Archive for: Entyvio

Takeda’s top five brands all grew substantially in FY 2022, none by less than 30 percent.

Thursday morning, Takeda reported its quarterly sales ending June 30, 2022. The company reported a 2.4% increase in revenue for the quarter from the same period in 2021, as well as changes to its pipeline, including a decision to drop a cancer therapeutic developed with Turnstone Biologics.